Just Another Korean

How the heck do I sound Scandi when I speak Engrish? Come on, AI.

@adamfeuerstein No love for Asia?

Based on this World Cup so far, the Africa Cup of Nations should receive A LOT more attention than it presently does. It has to be the strongest biennial soccer competition outside of the Euros. A team from Africa is going to win the World Cup soon.

@WorldCupMedia As always.

Can't believe Ronaldo didn't score 💔

🤣

Portugal 🤣🤣🤣🤣

@lucifer5670 보지냐 할머니?

할머니한테 존대말 써야지

@economy_kuromi 맛 없습니다.

이게 되나?

@1114 '씨발 이딴 실력으로 그 연봉이 목구멍으로 넘어가냐?'

국대를 보는 한국인 특징

@economy_kuromi @inomusiking 안 만나면 걱정 없음.

@inomusiking ㅇㅈ 진짜 확실한 사람 아니면 오프하면 안됨

온라인에서도 확실하게 드러나지만 오프라인에서도 마찬가지다. 몇 번 안 만나보고 좋다고 매번 같이 술 마시고 가는 곳마다 따라다니다가 몇 달 지나면 뒤에서 욕하고 다닌다. 어디든 똑같다. 급속도로 다가오는 사람을 경계하라.

@Agent0088156721 Yes, probably at the Truist conference.

@AnotherKoreanX Still hanging there?

Boston Red Sox it is. $ABVX

Cabo Verde defense is goated.

@pawcio2009 Cabo Verde goalkeeper GOAT.

Did Spain come to US for a vacation?

@A_May_MD @ALLKAResearch You might learn a thing or two.

🚨$ABVX just quietly dropped new slides again! Aside from showing a much better/clearer discussion of data/expectations and a clear goal to handhold the market with the upcoming part 2 dataset, these slides give us another key insight: $ABVX is finding the same expected background nNMSC/NMSC rates as @deathtouch2k and I have discussed. nNMSC/100PY expected range: 0.3-0.7 ↪️Obe's rate so far: ~0.59 NMSC/100PY expected range: 0.7-1.4 ↪️Obe's rate so far: ~0.79 And those are just for the 50mg doses...the Obe rates get further diluted massively if you were to include the 25mg dose levels, suggesting that the overall population is likely on the low end of expected cancer incidence. (Note the the calculations can change slightly once we get exact numbers of PY of exposure). So, even just looking at the 50mg dosing patient years, and not including the Part 2 data that might further reinforce safety, $ABVX is getting the word out that their EXISTING cancer event rates are ALREADY well within EXPECTATIONS...the market is clearly waiting for the Part 2 data before coming to this conclusion...but I personally don't see why we need to wait. These data are very clear. I continue to see no evidence of a "cancer signal" here, and I find the double digit stock price to be an absolute STEAL. $ABVX would very likely (IMO) have at least temporarily cracked $200/share on their absolutely unprecedented maintenance update without this (bogus?) "cancer scare". Those of us in the weeds have been able to see that the "cancer scare" was noise from the beginning...the company of course will be slower in reaching the market to get that word out and make people understand it, but IMO that's where we are heading. I would predict that stock price will follow!

If you send me death threats via DM because you think I've been jinxing $ABVX, I will gladly stop... NOT

@economy_kuromi x.com/i/status/20565…

another update came on Friday of last week; Tzield got approved for kids with Stage 3 T1D. this is good news because even though this drug has literally no benefit for insulin or HbA1c it was approved on the c-pep stat sig hit. I think we can put this in the "FDA trying to grow the market" camp of results. but this does effectively show us that the bar for FDA approval is quite low. when SABS shows up with a triple crown stat-sig on c-pep, insulin use, and HbA1c, how long is the BLA review going to be?

long🧵on $SABS. full report on substack. this is a full-on bullish report. can you believe it? I've been long since $2 and $20m mc. now sitting at $4.50 and $200m mc I'm still very bullish, but it's a very high risk biotech (as they all are)

@Agent0088156721 Logan.

@AnotherKoreanX Hanscom?

@Agent0088156721 just another monday

@AnotherKoreanX This looks like a…..

All 3 $LLY jets on the move. $ABVX? (Entertainment purposes only)

@A_May_MD In before someone says, "15% of the patients had only one kidney at the start of the trial."

So uhh, that new $NTLA publication that just dropped discloses that 15% of Lonvo-Z patients had liver enzyme elevations...Mostly within the first 6 weeks...the same pattern that we were seeing with the smaller sample size in ATTR before the Hy's Law case... AFAIK they did NOT disclose these liver AEs before🤔